Last reviewed · How we verify
NCT05696860
Microstream® Capnography in Endobronchial Ultrasonography Applications Under Sedation
NA trial testing Capnography Monitoring in Capnography in 100 participants. Status unknown.
1 February 2023
Quick facts
| Lead sponsor | Uludag University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | supportive care |
| Enrollment | 100 |
| Start date | 8 May 2019 |
| Primary completion | 1 February 2023 |
| Estimated completion | 28 February 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Capnography Monitoring
Conditions studied
- Capnography — all drugs for Capnography →
- Endobronchial Ultrasound — all drugs for Endobronchial Ultrasound →
Sponsor
Uludag University
Who can join
Eligibility, any sex, with Capnography or Endobronchial Ultrasound. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Purpose: Researchers wanted to investigate the effect of capnography monitoring in addition to routine monitoring on the development of desaturation and other vital parameters in endobronchial ultrasonography (EBUS) cases. Method: 100 patients who underwent EBUS under sedation will be included in this prospective and randomized controlled study. The cases will be divided into two groups of 50 people each. In the first group, standard monitoring will be performed, and in the second group, in addition to standard monitoring, capnography monitoring will be used. Heart rate, blood pressure, peripheral oxygen saturation (SpO2) values in both groups, end-tidal carbon dioxide (EtCO2), respiratory rate and integrated pulmonary index (IPI) values in the second group will be recorded in all cases. Disturbances in vital parameters and airway interventions, which were common in both groups, will ve compared. The frequency of problems detected by capnography monitoring in the second group will be examined.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05696860
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Uludag University trials
Trials by the same sponsor.
- NCT07478601 — Effect of Erector Spinae Plane Block on Postoperative Respiratory Function After Laparoscopic Cholecystectomy · NA · not yet recruiting
- NCT07440615 — Lower-Limb Muscle Mass and Cardiovascular and Muscular Performance in Males and Females · NA · not yet recruiting
- NCT07393620 — Predictive Value of aEEG and Cerebral Oxygenation on Neurological Outcomes in Newborns With Mild Hypoxic-Ischemic Enceph · not yet recruiting
- NCT07350018 — Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome · Phase 4 · not yet recruiting
- NCT07365605 — Lower-Limb Muscle Mass and Balance Performance · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05696860 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uludag University
- Last refreshed: 25 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05696860.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing